• Like

Loading…

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

Amap Overview 2010

  • 119 views
Published

 

Published in Business , Health & Medicine
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
119
On SlideShare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
2
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Association of Medical Affairs Professionals Overview
  • 2. Organization
    • Non-profit organization supporting Medical Affairs professionals in Pharmaceutical, Biotechnology and Medical Device Companies
  • 3. Mission
    • Sharing of best practices
    • Advocacy:
      • Set a stage for appropriate medical communications between medical professionals within pharmaceutical companies and physicians
  • 4. Mission
    • Sharing of best practices
    • Provide a platform for education and professional development for the membership
      • Create and establish understanding of what medical affairs function is all about
  • 5. Mission
    • Sharing of best practices
    • Self interest and higher interest
      • Self interest: training, articles, journals, best practice sharing, networking
      • Higher interest: scientific communication, ensuring that physicians understand the role of medical affairs, looking for innovative ways of doing studies
  • 6. Management
    • Operating Board of Directors
      • Elected – two year term
      • Each board seat focused on specific areas of the organization
      • Chairperson
        • Elected – two year term
    • Executive Board
      • Invited
      • Two year Term
  • 7. Current Status
    • Filing for 501(c)3 non profit status
    • Expanded enrollment to begin late 2010
    • Started Process of Setting up European Executive Board
    ©2010 Skila, a Sela2 Company. All Rights Reserved. Proprietary and Confidential.
  • 8. Executive Committee ©2010 Skila, a Sela2 Company. All Rights Reserved. Proprietary and Confidential. Simon Mason Skila Dr. Steven James Allergan Kathy Presto Roche Dr. Ken Newman Medical Affairs Consultant – former Boehringer Ingelheim/Forest Shahin Gharakhanian Vertex Pharma Dr. Charles Hugh-Jones Sanofi-Aventis Dr. William Sigmund GSK Dr. Paul Weber PTC Biotech